Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids for Neuroprotection in Contact Sports
NCT07715864Phase 2Recruiting
- Sponsor
- University of Regina
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in concussion (mTBI) (2 arms), sponsored by University of Regina. Primary endpoints: Plasma cannabidiol metabolite concentration at 8 weeks, Plasma tetrahydrocannabinol metabolite concentration at 8 weeks and 8 more. Started Jun 2026; status: recruiting.
02
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT07715864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07715864.